Losartan [losartan]
- Terms
-
draselná sůl losartanu
Lorista
losartan draselná sůl
losartanum kalicum
Lozap
Sangona
-
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
Cozaar
DuP-753
Losartan Monopotassium Salt
Losartan Potassium
MK-954
MK954
An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
- DUI
- D019808 MeSH Browser
- CUI
- M0029400
- Previous indexing
- Biphenyl Compounds (1990-1997); Imidazoles (1990-1997); Tetrazoles (1990-1997)
- History note
- 98; use LOSARTAN (NM) 1990-97
- Public note
- 98; LOSARTAN was indexed under IMIDAZOLES 1990-97, TETRAZOLES 1990-97, & BIPHENYL COMPOUNDS 1990-97
Allowable subheadings
- AD
- administration & dosage 62
- AE
- adverse effects 15
- AG
- agonists 0
- AA
- analogs & derivatives 23
- AN
- analysis 0
- AI
- antagonists & inhibitors 1
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 1
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 6
- PK
- pharmacokinetics 9
- PD
- pharmacology 75
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 112
- TO
- toxicity 0
- UR
- urine 0